New York City-based lending platform EVEN Financial has secured $2.8 million in seed funding. Canaan Partners led the round with participation from other investors that included Lerer Hippeau Ventures, Brooklyn Bridge Ventures, Conversion Capital, Social Leverage and 555 Capital.
3 min read · 12 March 2015
Israeli educational tech startup Lingua.ly has secured $1 million in funding. The backers were unnamed private and government investors.
3 min read · 12 March 2015
San Francisco-based Bugcrowd, a provider of crowdsourced security testing for the enterprise, has received $6 million in Series A funding. Costanoa Venture Capital led the round with participation from other investors that included Rally Ventures, Paladin Capital Group and Blackbird Ventures.
4 min read · 12 March 2015
San Mateo, California-based Allergen Research Corp, which develops treatments for food allergies, has closed $80 million in Series B funding. Foresite Capital led the round with participation from Longitude Capital, Fidelity Management & Research Company, Aisling Capital, Adage Capital, RA Capital Management and Palo Alto Investors. In conjunction with the funding, Dr. Jim Tananbaum, CEO and managing director of Foresite Capital and Stacey Seltzer, a partner at Aisling Capital, have been added to ARC's board of directors.
4 min read · 12 March 2015
Docker Inc has acquired Kitematic, an open source software tool provider. No financial terms were disclosed. Docker is backed by AME Cloud Ventures, Benchmark, Greylock Partners, Insight Venture Partners, Sequoia Capital, SV Angel, Trinity Ventures and Y Combinator.
4 min read · 12 March 2015
Palo Alto, California-based The Hive, an incubator, accelerator and early-stage investor, has closed its second fund at $22 million. According to the firm, The Hive II will focus on backing data-driven applications in enterprise, internet of things and online segments.
4 min read · 12 March 2015
Malvern, Pennsylvania-based PhaseBio Pharmaceuticals Inc, which is focused on developing treatments for metabolic and specialty cardiopulmonary disorders, has secured $40 million in Series C funding. AstraZeneca led the round with participation from New Enterprise Associates, Hatteras Venture Partners, Johnson & Johnson Innovation – JJDC and Fletcher Spaght Ventures. In addition to the funding, Dr. Michael Gutch of AstraZeneca has been added to PhaseBio's board of directors while Donald Dwyer, also of AstraZeneca, has become a board observer.
4 min read · 12 March 2015
La Jolla, California-based Kura Oncology Inc, a biopharmaceutical company focused on treating solid tumors and blood cancers, has raised $60 million in a private placement. EcoR1 Capital was the lead investor. Other investors included Fidelity Management & Research Company, ARCH Venture Partners, Tavistock Life Science's Boxer Capital, Partner Fund Management and Nextech Invest. Leerink Partners LLC was lead placement agent while National Securities Corp and Livingston Securities LLC were co-placement agents for the private placement.
5 min read · 12 March 2015
Davis, California-based Arcadia Biosciences, an agricultural products developer, has named Thomas P. O'Neil as chief financial officer. Previously, O'Neil worked at Sorbent Therapeutics Inc. Arcadia’s backers include Mandala Capital Limited, CMEA Capital, BASF Venture Capital and Saints Capital.
2 min read · 12 March 2015
San Francisco and New York City-based Greenhouse Software, a recruiting optimization platform, has secured $13.6 million in Series B funding. Benchmark led the round with participation from The Social+Capital Partnership, Felicis Ventures and Resolute Ventures. According to the company, the capital will be used for sales, marketing, services and product development.
4 min read · 12 March 2015
